These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17695429

  • 1. Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.
    Ozaki T, Tamura K, Satoh T, Kurata T, Shimizu T, Miyazaki M, Okamoto I, Nakagawa K, Fukuoka M.
    Anticancer Res; 2007; 27(4C):2657-65. PubMed ID: 17695429
    [Abstract] [Full Text] [Related]

  • 2. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
    Rino Y, Takanashi Y, Yukawa N, Saeki H, Wada H, Kanari M, Yamada R, Satoh T, Yamamoto N, Imada T.
    Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.
    Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3402-7. PubMed ID: 16740764
    [Abstract] [Full Text] [Related]

  • 5. Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer.
    Kunisaki C, Takahashi M, Nagahori Y, Makino H, Takagawa R, Sato T, Oshima T, Fujii S, Kosaka T, Ono HA, Akiyama H, Shimada H.
    Anticancer Res; 2008 Jun 01; 28(4C):2473-8. PubMed ID: 18751437
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
    Takahashi I, Emi Y, Kakeji Y, Tokunaga E, Ushiro S, Oki E, Watanabe M, Baba H, Maehara Y.
    Oncol Rep; 2006 Apr 01; 15(4):849-54. PubMed ID: 16525670
    [Abstract] [Full Text] [Related]

  • 7. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Ueda Y, Yamagishi H, Ichikawa D, Morii J, Koizumi K, Kakihara N, Shimotsuma M, Takenaka A, Yamashita T, Kurioka H, Nishiyama M, Morita S, Nakamura K, Sakamoto J.
    Oncology; 2005 Apr 01; 69(3):261-8. PubMed ID: 16138002
    [Abstract] [Full Text] [Related]

  • 8. Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.
    Kim YH, Seo HY, Jeen YT, Kim HK, Shim BY, Yang J.
    Cancer Chemother Pharmacol; 2009 Jan 01; 63(2):253-60. PubMed ID: 18493761
    [Abstract] [Full Text] [Related]

  • 9. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
    Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS.
    Cancer Chemother Pharmacol; 2008 Apr 01; 61(5):837-45. PubMed ID: 17579864
    [Abstract] [Full Text] [Related]

  • 10. Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.
    Zang DY, Yang DH, Lee HW, Hwang SW, Song HH, Jung JY, Kwon JH, Kim HJ, Kim JH, Park SR, Kim MJ, Jang KM, Park CK, Kim JH, Lee BH.
    Cancer Chemother Pharmacol; 2009 Feb 01; 63(3):509-16. PubMed ID: 18481067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
    Morita S, Nakata B, Tsuji A, Mitachi Y, Shirasaka T, Saji S, Ohashi Y, Sakamoto J, Hirakawa K.
    Jpn J Clin Oncol; 2007 Dec 01; 37(12):924-9. PubMed ID: 18211983
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer.
    Sym SJ, Hong J, Jung M, Park J, Cho EK, Lee WK, Chung M, Kim HS, Lee JH, Shin DB.
    Cancer Chemother Pharmacol; 2012 Aug 01; 70(2):277-84. PubMed ID: 22752217
    [Abstract] [Full Text] [Related]

  • 14. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S, Tomidokoro T, Fukunari H, Sato T, Hatano T, Nishimura A, Kawauchi Y, Nikkuni K, Shimizu T, Sato T, Yanagi M, Takahashi S, Yoshida H, Sugita M, Hayashi T.
    Cancer Chemother Pharmacol; 2009 Jan 01; 63(2):267-73. PubMed ID: 18379784
    [Abstract] [Full Text] [Related]

  • 15. Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.
    Shigeyasu K, Kagawa S, Uno F, Nishizaki M, Kishimoto H, Gochi A, Kimura T, Takahata T, Nonaka Y, Ninomiya M, Fujiwara T.
    Cancer Chemother Pharmacol; 2013 Apr 01; 71(4):937-43. PubMed ID: 23355040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen.
    Sato Y, Kondo H, Honda K, Takahari D, Sumiyoshi T, Tsuji Y, Yoshizaki N, Niitsu Y.
    Int J Clin Oncol; 2005 Feb 01; 10(1):40-4. PubMed ID: 15729600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.